英诺特：获胶质纤维酸性蛋白测定试剂盒产品资质

Core Viewpoint - The company has recently obtained a new product qualification for the GFAP assay kit, which is a significant development in its product portfolio and enhances its market competitiveness [1] Group 1: Product Qualification - The company has acquired a product qualification for the GFAP assay kit, which utilizes a single-molecule immunofluorescence method [1] - The registration number for this product is 京械注准20262400042, with the issuance date set for February 5, 2026, and a validity period until February 4, 2031 [1] Group 2: Market Impact - This product is intended for the quantitative detection of GFAP levels in human plasma, marking the company's first registered assay product in the field of neurological system testing [1] - The introduction of this product expands the company's product range and enhances its core competitiveness in the market [1] - However, the sales of the product may be influenced by various factors, making the impact on performance difficult to predict at this time [1]